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Abstract 
In the last 10 years, research on the human microbiome has grown exponentially due to 
the increasing understanding of its effects on human health. The gut-brain axis has become one 
area of focus, linking gut health and mental disorders. This review of the literature will examine 
the connection between depression and gut health, primarily mediated by the gut microflora. Due 
to the complex nature of studying the gut-brain axis and the heterogeneity of depression, recent 
studies have faced some difficulty in finding significant results based on isolated nutrients, 
foods, supplements, or probiotics. This proposal seeks to build on prior research to produce an 
inclusive whole food-based nutrition intervention that potentially will have a more significant 
impact on depressive disorders. This research will be combining well studied probiotics with a 
beneficial dietary pattern in the hopes of creating a protocol that yields a more pronounced 
reduction on depressive symptoms, which could be used in a clinical trial or as an adjuvant 
treatment.  
Keywords: Gut-Brain Axis, Depression, Mental Health, Gut Microbiome, Probiotics, 
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Introduction 
Depression Significance and Diagnostic Criteria 
Depression is one of the most common mental disorders globally and a leading cause of 
disability affecting more than 300 million people worldwide (Kessler & Bromet, 2013; World 
Health Organization, 2018).  Depression greatly reduces quality of life and can have major 
personal, professional, and social consequences. It also has the capability to bring on suicidal 
thoughts and potentially lead to death (Popa & Ladea, 2012). According to the Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.), the myriad of depressive disorders share 
common diagnostic criteria including: “the presence of sad, empty, or irritable mood, 
accompanied by somatic and cognitive changes that significantly affect the individual’s capacity 
to function” (American Psychiatric Association, 2013). The different types of depressive 
disorders primarily differ because of timing, duration, or presumed etiology (American 
Psychiatric Association, 2013). It is understood that depression can stem from biological, social, 
and environmental factors. The present research seeks to address possible biological and 
environmental origins of depression.  
Depression as an Inflammatory Disease 
 Current pharmacological treatments for depression involve the use of medications that 
primarily function to adjust neurotransmitter activity, but these treatments can cause severe side 
effects and withdrawal symptoms (National Institute of Mental Health, 2018; Wallace & Milev, 
2017). A recent study examining the efficacy on antidepressants found them to be much less 
clinically significant than previously thought (Moncrieff & Kirsch, 2005). The common notion 
that depression stems solely from neurochemical imbalances has more recently been 
reconsidered and depression is now hypothesized to be an inflammatory disease (Berk et al., 
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2013).  Common biomarkers of depression include elevations of pro-inflammatory cytokines 
including interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor - alpha (TNF-a), and  
c-reactive protein (CRP) (Dowlati et al., 2010; Gururajan, Clarke, Dinan, & Cryan, 2016). It’s 
also common to see evidence of stress-related physiology, such as elevated cortisol levels 
(Connor & Leonard, 1998).  Brain-related biomarkers of depression include lowered levels of 
dopamine, serotonin Gamma-Aminobutyric Acid (GABA), and various neurotrophic factors, 
especially brain-derived neurotrophic factor (BDNF) (Strawbridge, Young, & Cleare, 2017; 
Gururajan et al., 2016). All these biomarkers suggest depression to be highly correlated to 
inflammation, stress, immune dysfunction, and a hyperactive hypothalamus-pituitary-adrenal 
(HPA) axis (Sandhu et al., 2017). 
Study Aims 
Berk et al. (2013) have examined the many possible sources of inflammation that may be 
influencing depression. Sources of inflammation can stem from biological, social, and 
environmental factors which helps explain the heterogeneity of depression. Research has shown 
a strong correlation between depression and gastrointestinal dysfunction, shown in the 
comorbidity of depression with many gastrointestinal disorders and related inflammatory 
responses (Mangiola et al., 2016). This has led to an increased interest in studies surrounding 
nutritional psychiatry, neurogastroenterology, and the gut-brain-axis (Logan & Katzman, 2005). 
This paper will be examining the role of dietary patterns and gut microflora as mediators of 
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Gut-Brain Axis  
The Gut-Brain Axis as a Mediator of Depression 
 In the last decade, a growing field of research has emerged looking into the bidirectional 
connection between the central nervous system (CNS) and the gastrointestinal (GI) tract, which 
is now known as the gut-brain axis. The cross talk between the GI tract and the CNS is mediated 
through the autonomic and enteric nervous systems, immune system, and endocrine system 
(Sandhu et al., 2017). The human GI tract is also home to over 100 trillion bacteria which make 
up the gut microbiome. This microbiome is a very influential part of the gut-brain axis and has a 
significant impact on human health by maintaining the intestinal barrier, supporting immune 
function, metabolizing nutrients, producing short chain fatty acids (SCFAs), and producing 
neurochemicals, such as 90% of the bodies serotonin (Mangiola et al., 2016; Sandhu et al., 
2017). The importance of nutrition and maintaining a healthy gut microbiome has been well 
established, but the role these play in psychiatric disorders is emerging in research with 
promising findings. The gut microbiome may modulate cognitive functioning and behavior 
through possible mechanisms involving the immune system, HPA axis, inflammation, and the 
production of neurochemicals and neurohormones (Sandhu et al., 2017). Maintenance of a 
healthy gut microbiome has the potential to modulate levels of anti-inflammatory cytokines, 
reduce oxidative stress, and increase BDNF, GABA, and serotonin, all of which have negative 
correlations with depression (Logan & Katzman, 2005).   
The Gut-Microbiome - An Ecosystem Within Us 
 The gut microflora is unique to every individual and is influenced by several factors 
including genetics, lifestyle, birthing method, antibiotic history, and dietary patterns (Sandhu et 
al., 2017). It is well established which bacteria are beneficial versus harmful, and the balance 
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between positive and negative species is essential to host health. An unbalanced microflora is 
known as dysbiosis and is directly correlated to a plethora of disorders and diseases, one of 
which being depression. Although everyone’s microbiome is distinct, similar populations share 
certain species, quantities, and diversity (Sandhu et al., 2017).  Healthy individuals are primarily 
populated by the phyla Firmicutes and Bacteroidetes, which contain many beneficial species 
including the well-known Bifidobacterium and Lactobacillus (Johnson et al., 2012).  Individuals 
with depressive disorders have shown to have an abundance of Enterobacteriaceae (phyla 
containing mostly pathogenic species), and lower levels of Bifidobacterium and Lactobacillus 
(gram positive beneficial bacteria) when compared to healthy subjects (Aizawa et al., 2016; 
Jiang et al., 2015; Sandhu et al., 2017). In a study by Zheng et al. (2016), fecal microflora from 
patients with major depressive disorder (MDD) were transplanted into germ free mice. This 
induced depressive-like behaviors and caused metabolic dysfunction when compared to mice 
who received fecal microflora transplants from healthy subjects (Zheng et al., 2016). There have 
been numerous other demonstrations that depression may stem from negative alterations in gut 
microflora.  
From Probiotics to Psychobiotics 
Probiotics are defined as “live microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host” (Hill et al., 2014, p. 506). Probiotics have been 
prescribed by doctors for many gut-related disorders, but as the understanding of the gut-brain 
axis has evolved a new era of probiotics has been termed “psychobiotics” for their influence on 
the CNS, cognition, and behavior (Dinan, Stanton, & Cryan, 2013). In a systematic review on the 
effects of probiotics on the CNS, it was found that probiotics can improve CNS functioning 
possibly through increasing BDNF levels, enhancing serum tryptophan, and decreasing pro-
 
A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     7 
inflammatory cytokines (Wang, Lee, Braun, Enck, 2016). In a study on Ulcerative Colitis, 
probiotics were found to diminish inflammation by decreasing IL-6 and TNF-a concentrations, 
both of which are inflammatory biomarkers of depression (Hegazy & El-Bedewy, 2010).  
Akkasheh et al. (2015), found that probiotic treatment to patients with MDD significantly 
reduced signs of oxidative stress and CRP levels, other inflammatory biomarkers of depression. 
A growing body of research is examining the efficacy of specific probiotic strains for the 
treatment of depression, those with promising results are summarized and presented in Table 1. 
These studies focus on increasing the quantity and diversity of beneficial gut bacteria, primarily 
using Bifidobacteria and Lactobacillus supplementation, to bring dysbiotic microflora back to a 
healthy status.   
Table 1. Probiotics for Depression  
This table provides a list of probiotic strains with corresponding evidence in preclinical and 
clinical studies for the treatment of depressive disorders or associated risk factors. Clinical 
diagnosis, method of probiotic treatment, and depression scales may differ between studies due 
to the heterogeneity of depression. 
 
Probiotic Strain Authors Study Design Overview 






Probiotic formula (L. acidophilus, L. casei, B. 
bifidum) administered to 20 patients with MDD 
over 8 weeks significantly decreased scores on 
Beck Depression Inventory  









20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  




B. Infantis proved to be nearly as effective as 
citalopram (a common antidepressant) in 
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normalizing forced swim test behaviors in a rat 
maternal separation model, which is a reliable 
marker of antidepressant activity.  









20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  






The probiotic formula of L. helveticus and B. 
longum reduced anxiety and in preclinical rats 
and had beneficial psychological effects 
(including depression reduction) in 26 human 
volunteers. 
 Pinto-Sanchez 






Pilot study found that B. longum reduces 
depression and increases quality of life in 22 
patients with IBS compared to controls.  






Probiotic formula (L. acidophilus, L. casei, B. 
bifidum) administered to 20 patients with MDD 
over 8 weeks significantly decreased scores on 
Beck Depression Inventory  









20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  








20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
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assessment  precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  






Probiotic formula (L. acidophilus, L. casei, B. 
bifidum) administered to 20 patients with MDD 
over 8 weeks significantly decreased scores on 
Beck Depression Inventory  









20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  






The probiotic formula of L. helveticus and B. 
longum reduced anxiety and in preclinical rats 
and had beneficial psychological effects 
(including depression reduction) in 26 human 
volunteers. 




L. plantarum effectively decreased serum IL-6 
levels and improved depressive behaviors in 
mice with early life stress 
L. reuteri  Ma, Forsythe, 
& Bienenstock 
(2004)  
Preclinical study L. Reuteri directly inhibited IL-8 and TNF-alpha, 
promoting an anti-inflammatory effect on human 
epithelial cells.  






Study showed a significant reduction of 
depressive and anxiety postpartum symptoms in 
212 women compared to placebo group. 









20 healthy participants were administered a 
probiotic formulation of B. Bifidum, B. lactis, L. 
acidophilus, L. brevis, L, casei, L. salvarius, and 
L. lactis for a 4-week period. Leiden Index of 
Depression Sensitivity Scale was used to 
measure cognitive reactivity to sad mood (a 
precursor for depression) and the probiotic 
formulation showed significant reductions on 
scale.  
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Research Significance and Recommendations 
Based on the results of these articles, it’s reasonable to conjecture that a combination of 
these beneficial probiotic species may be a promising option for the prevention and treatment of 
depression. An important thing to mention is that few of these studies have large sample sizes, 
control for diet and prebiotic consumption, use modes of transmission beside capsulized 
probiotics, or analyze the stool to confirm the probiotics were able to colonize in the lower GI 
tract. The efficacy of probiotics relies on their ability to survive through the stomach and adhere 
permanently to the epithelium of the large intestine. Their ability to do so depends on how the 
cultures were administered, the presence of prebiotics, and the quantity and quality of the 
probiotic culture (Johnson et al., 2012). Although these studies have found clinically relevant and 
promising results, it is possible that these findings could be improved if more measures are taken 
to ensure the colonization of probiotic species in the GI tract.  
The Role of Nutrition 
The Importance of Diet and Prebiotics 
The most effective way to rapidly improve the gut microbiome and promote the 
colonization and growth of beneficial species is through diet (Singh et al., 2017). Although the 
use of probiotic supplements has demonstrated potential effectiveness in promoting the integrity 
of the microbiome and improving depressive symptoms, research suggests that the influence of a 
healthy diet and consumption of probiotic foods and drinks may be more influential (Walker et 
al, 2011). The probiotic research presented in Table 1 primarily establishes what specific species 
show the most promise in influencing mood and depressive symptoms. These “psychobiotic” 
species include B. bifidum, B. infantis, B. lactis, B. longum, L. acidophilus, L. brevis, L. casei, L. 
helveticus, L. plantarum, L. reuteri, L. rhamnosus, and L. salivarius. These species can be found 
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in a variety of fermented foods and drinks including fermented dairy products, sauerkraut, 
kimchi, kombucha, etc. Another main way diet supports microbiome health is from the presence 
of prebiotics, specific nondigestible foodstuffs, that feed beneficial bacteria which then 
outcompete harmful species (Singh et al, 2017). Prebiotics include fructooligosaccharides, 
galactooligosaccharides, lactulose, cereal fibers, resistant starches, lactosucrose, soybean, and 
oligosaccharides (Johnson et al., 2012). To see more significant clinical results for treating 
depression the consumption of probiotics, prebiotics, and quality of diet must be established to 
improve the gut microbiome and feed these psychobiotic species. 
Dietary Patterns  
A fundamental approach to achieving optimal function of the gut-brain axis is through 
specific nutritional interventions focused on dietary patterns. While some research has focused 
on the use of specific vitamins, minerals, and other supplements to promote gut and brain health, 
results are mixed (Wallace & Milev, 2017). This has led many to propose that, rather than 
focusing on isolated nutrients, examining diet patterns as a whole may be more impactful when 
studying mental health, especially depression (Del Chierico, Vernocchi, Dallapiccola, & 
Putignani, 2014).  There is a growing body of research that supports the Mediterranean diet as an 
effective prevention or treatment plan for depression as they are inversely related (Psaltopoulou 
et al., 2013; Sanchez-Villegas et al., 2007; Sandhu et al., 2017). Correspondingly, there is a 
strong correlation between the Western diet (high in refined carbohydrates, animal protein and 
fat) and depression, along with the comorbidity of many other metabolic disorders (Jacka et al, 
2010; Psaltopoulou et al., 2013). Studies continue to evaluate the possible antidepressant 
properties of the Mediterranean dietary pattern, one of which may be the positive impact it has 
on the gut microbiome (Sanchez-Villegas et al., 2007). Research has compared the influence of 
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dietary patterns on gut microflora and found that Western diets limit microflora density and show 
a reduction in amounts of Bifidobacteria and Lactobacillus and an increase in Enterobacteria 
(Singh et al., 2017). On the other hand, the Mediterranean diet increases microflora diversity and 
promotes the growth of Bifidobacteria and Lactobacillus (see figure 1.) (Singh et al., 2017).  
 
 
Figure 1. Western diet vs. Mediterranean diet effects on microflora (Singh et al., 2017).  





The Mediterranean Diet and the Gut Microbiome  
 
The Mediterranean Diet: What is it? 
                      
 The Mediterranean diet has come to be known as one of the healthiest and most 
beneficial ways of eating. The Mediterranean diet is an eating pattern characterized by daily 
intake of unrefined grains, vegetables, fruit, olive oil, and dairy, with a moderate intake of fish, 
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Figure 2. The Mediterranean Diet food pyramid (Trichopoulou, 2004).  
                             
 
Mediterranean Diet Carbohydrates (Prebiotics)  
 
   In a study done by Filippis et al. (2016), the microbiomes of 153 volunteers were 
analyzed in relation to their adherence to a Mediterranean diet. The results of the study found 
that dietary patterns closest to that of the Mediterranean diet were associated with healthier 
microbiome profiles compared to those consuming a Western diet (Filippis et al., 2016). A large 
portion of the Mediterranean diet is composed of fruits, vegetables, and foods high in fiber, 
which provide the variety of prebiotics that promote beneficial gut bacteria. Prebiotics, such as 
fructooligosaccharides, oligosaccharides, cereal fibers, and resistant starches found in the 
Mediterranean diet, are often indigestible carbohydrates that can only be broken down by 
beneficial species such as Bifidobacterium and Lactobacillus. The consumption of these 
prebiotics allows beneficial gut microbes to produce SCFA, such as butyrate, that directly 
support digestive function and produce anti-inflammatory effects (Singh et al., 2017). Prebiotic 
consumption is associated with reductions of pro-inflammatory cytokine IL-6, increases in the 
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anti-inflammatory cytokine IL-10, and other positive metabolic markers while also increasing 
microflora density and diversity (Martinez et al., 2013; Singh et al., 2017).  
Mediterranean Diet Proteins 
Aside from its high content of beneficial carbohydrates, the Mediterranean dietary pattern 
also emphasizes a reduced consumption of meat and promotes the ingestion of healthy fats. Meat 
intake and fat quality have also shown to influence the composition of the gut microbiome and 
may add to the success of the Mediterranean diet in reducing depression. Plant protein rich diets 
increase microflora diversity and can increase beneficial microbes, but diets with high 
consumption of animal-based protein produce an opposite effect. Diets high in animal-based 
protein increase counts of Bacteroides, Alistipes, and Bilophila, which increase protein 
fermentation that lead to toxic metabolites. These metabolites are associated with the 
development of cancer, irritable bowel disease, and cardiovascular disease (Singh et al. 2017; 
Sandhu et al., 2017).  De Filippo et al. (2010), found that an animal protein rich diet produces 
fewer SCFA’s, which protect the gut membrane and reduce inflammation. Diets high in animal 
protein and low in prebiotic foods promote the colonization of harmful species, which degrades 
the health of the gut microflora.  
Mediterranean Diet Fats 
 Other nutrient components of the Mediterranean diet may also serve as protective agents 
against depression. The emphasis on healthy mono- and polyunsaturated fat (PUFA) 
consumption in the Mediterranean diet increases omega-3 levels which may play a major role in 
inflammatory responses (Simopoulos, 2002). The ratio of omega-6 to omega-3 PUFA 
consumption is understood to be of importance when it comes to human health. A high ratio of 
omega-6/omega-3 has been highly correlated to inflammatory diseases, especially in Western 
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cultures where the average PUFA ratio is 16-1 when it is recommended to be 2-1 or 1-1 
(Simopoulos, 2002). The Mediterranean diet supports a high consumption of fish and olive oil 
(both high in omega-3) which has shown to decrease pro-inflammatory markers such as IL-6, 
CRP, and TNF-a (Bountziouka et al., 2009).  Studies have shown that a lack of dietary omega-3 
is correlated with depression, and populations with a higher PUFA ratio have higher prevalence 
of major depressive disorders (Bountziouka et al., 2009).  
Conclusions  
Summary of Research 
 As the understanding of the gut-brain axis evolves, research continues to find connections 
between depression, gut microflora, and the Mediterranean diet. Studies continue to search for 
isolated solutions from probiotics and nutritional aspects, but it is apparent the success from 
recent research stems from a cumulative effect that diet has on the microflora, and that the 
microflora has on the brain. As depression is now seen as an inflammatory disease, it is crucial to 
pinpoint the root of this inflammation and find functional ways to reduce it. As the GI tract is the 
body’s largest immune organ, the idea that gut inflammation can be the underlying cause of 
some depressive disorders is not unlikely. The culmination of this research has uncovered the 
mechanisms by which diet can improve gut microflora, and in turn may decrease depressive 
symptoms. Figure 3 presents a simplified version of the mechanistic actions of this nutrition 
intervention. Essentially, what we eat influences the composition of our gut microbiota and thus 
what metabolites are produced. When eating a healthy diet rich in probiotics and prebiotics we 
feed the beneficial microbes in our gut and they return the favor by producing anti-inflammatory 
metabolites, energy, and beneficial neurochemicals. These metabolites then reduce systemic 
inflammation by regulating the immune system and calming the HPA axis, which helps bring the 
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body back into homeostasis and reduces depressive symptoms. The beneficial neurochemicals 
produced by the microflora are able to pass the blood-brain barrier and regulate levels of BDNF, 
GABA, dopamine, and serotonin in the brain, also thus reducing depressive symptoms.  
 





Proposed Nutrition Intervention 
Through this research, a nutrition intervention based on a Mediterranean dietary model 
with an emphasis on the consumption of probiotic and prebiotic foods may successfully prevent/ 
treat depressive disorders. The outline of this intervention is presented in Figure 4.  
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Figure 4.  Nutrition Intervention proposal for the prevention/ treatment of depression.  
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This nutrition intervention is not all inclusive, but a recommendation based on the present 
research. This intervention is a non-harmful, holistic, accessible, and potentially effective way to 
prevent or manage depressive symptoms. For depressed populations who have a history of 
antibiotic use, poor dietary habits, or other inflammatory or GI problems (such as eczema or 
IBS) this nutrition intervention could serve as an extremely beneficial solution. This intervention 
is not meant to replace current depression treatments and individuals should always consult their 
physician before making any large scale dietary changes. This recommendation is meant to be a 
supplemental, holistic way to potentially address depression and more research is needed to 
support its efficacy in clinical trials.  
Future Perspectives 
In the future, research on this topic must approach it from a more functional direction by 
implementing larger scale nutrition interventions and probiotic treatments to modulate 
depression. Present research focused on isolated nutrients and single probiotic strains continues 
to show promise but lacks large sample sizes and high significance. No single nutrient or single 
probiotic strain is going to solve the depression epidemic. Dietary habits need to be controlled, 
effective methods to promote probiotic colonization need to be used, and stool samples must be 
analyzed to produce more conclusive results. Diet, microflora, and mood are clearly interrelated, 
and more research is necessary to reveal the mystery of this connection. As projects such as the 
Human Microbiome Project (National Institute of Health) make advancements in uncovering the 
complex world of our microbiomes, more studies need to solidify the best practices for ensuring 
colonization of beneficial microbes in the GI tract and how nutrition affects the ecosystem in our 
gut. Research on the gut microbiome and the influence of nutrition expands beyond depression to 
a variety of other psychiatric disorders, as well as numerous metabolic disorders. As this field of 
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research grows, it is very clear the ecosystems within our bodies may play a much larger role in 
our mental health than previously understood.  
Limitations 
 
 One of the main limitations of this research is the heterogeneity of depression and how 
this causes many discrepancies among current research. There are a multitude of diagnoses for 
depressive disorders and a similar plethora of scales to measure them. The present research only 
addresses depression from an inflammatory perspective that focuses on inflammation stemming 
from the gut. This does not account for possible other roots of inflammation but may serve as a 
way to promote anti-inflammatory responses systemically. This nutrition intervention may not be 
applicable among all people due to the personalized nature of the gut microbiome. Some 
research has supported a personalized nutrition intervention based off individual microbiomes 
and genetics. The present approach supports a general dietary plan that can be modified by 
















A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     20 
References 
 
Aizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., … Kunugi, H. 
 (2016). Possible association of Bifidobacterium and Lactobacillus in the gut microbiota  
of  patients with major depressive disorder. Journal of Affective Disorders, 202, 254–257.  
https://doi.org/10.1016/j.jad.2016.05.038 
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M.,  
… Esmaillzadeh, A. (2016). Clinical and metabolic response to probiotic administration  
in patients with major depressive disorder: A randomized, double-blind,  
placebo-controlled trial. Nutrition, 32(3), 315–320.  
https://doi.org/10.1016/j.nut.2015.09.003 
American Psychiatric Association. (2013). Depressive disorders. Diagnostic and Statistical  
Manual of Mental Disorders  (5th ed.). 
https://doi.org/10.1176/appi.books.9780890425596.dsm04 
Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., … Maes, M. (2013).  
So depression is an inflammatory disease, but where does the inflammation come from?  
BMC Medicine, 11, 200. https://doi.org/10.1186/1741-7015-11-200 
Bountziouka, V., Polychronopoulos, E., Zeimbekis, A., Papavenetiou, E., Ladoukaki, E.,  
Papairakleous, N., … Panagiotakos, D. (2009). Long-Term Fish Intake Is Associated  
With Less Severe Depressive Symptoms Among Elderly Men and Women: The MEDIS  
(MEDiterranean ISlands Elderly) Epidemiological Study. Journal of Aging and Health,  




A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     21 
Connor, T. J., & Leonard, B. E. (1998). Depression, stress and immunological activation: The  
role of cytokines in depressive disorders. Life Sciences, 62(7), 583–606.  
https://doi.org/10.1016/S0024-3205(97)00990-9 
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., …  
Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative  
study in children from Europe and rural Africa. Proceedings of the National Academy of 
Sciences of the United States of America, 107(33), 14691–14696. 
https://doi.org/10.1073/pnas.1005963107 
Del Chierico, F., Vernocchi, P., Dallapiccola, B., & Putignani, L. (2014). Mediterranean Diet  
and Health: Food Effects on Gut Microbiota and Disease Control. International Journal  
of Molecular Sciences, 15(7), 11678–11699. https://doi.org/10.3390/ijms150711678 
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010). Effects of  
the probiotic Bifidobacterium infantis in the maternal separation model of depression.  
Neuroscience, 170(4), 1179–1188. https://doi.org/10.1016/j.neuroscience.2010.08.005 
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013). Psychobiotics: A Novel Class of Psychotropic.  
Biological Psychiatry, 74(10), 720–726. https://doi.org/10.1016/j.biopsych.2013.05.001 
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L.  
(2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5),  
446–457. https://doi.org/10.1016/j.biopsych.2009.09.033 
Filippis, F. D., Pellegrini, N., Vannini, L., Jeffery, I. B., Storia, A. L., Laghi, L., … Ercolini, D.  
(2016). High-level adherence to a Mediterranean diet beneficially impacts the gut  
microbiota and associated metabolome. Gut, 65(11), 1812–1821.  
https://doi.org/10.1136/gutjnl-2015-309957 
 
A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     22 
Gururajan, A., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016). Molecular biomarkers of  
depression. Neuroscience & Biobehavioral Reviews, 64, 101–133.  
https://doi.org/10.1016/j.neubiorev.2016.02.011 
Hegazy, S. K., & El-Bedewy, M. M. (2010). Effect of probiotics on pro-inflammatory cytokines  
and NF-κB activation in ulcerative colitis. World Journal of Gastroenterology : WJG,  
16(33), 4145–4151. https://doi.org/10.3748/wjg.v16.i33.4145 
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., … Sanders, M. E.  
(2014). Expert consensus document: The International Scientific Association for  
Probiotics and Prebiotics consensus statement on the scope and appropriate use of the 
term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. 
https://doi.org/10.1038/nrgastro.2014.66 
Jacka, F. N., Pasco, J. A., Mykletun, A., Williams, L. J., Hodge, A. M., O’Reilly, S. L., … Berk,  
M. (2010). Association of Western and Traditional Diets With Depression and Anxiety in  
Women. American Journal of Psychiatry, 167(3), 305–311.  
https://doi.org/10.1176/appi.ajp.2009.09060881 
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., … Ruan, B. (2015). Altered fecal  
microbiota composition in patients with major depressive disorder. Brain, Behavior, and  
Immunity, 48, 186–194. https://doi.org/10.1016/j.bbi.2015.03.016 
Johnson, L. R., Ghishan, F. K., Kaunitz, J. D., Merchant, J. L., Said, H. M., & Wood, J. (2012).  
Gastrointestinal Microbial Ecology with Perspectives on Health and Disease, in M.G.  
Gillilland, V. B. Young, & G.B. Huffnagle, Physiology of the Gastrointestinal Tract (pp.  
1119-1134). San Diego, CA: Elsevier Science & Technology 
 
 
A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     23 
Kessler, R. C., & Bromet, E. J. (2013). The epidemiology of depression across cultures. Annual  
Review of Public Health, 34, 119–138. https://doi.org/10.1146/annurev-publhealth-
031912-114409 
Liu, Y.-W., Liu, W.-H., Wu, C.-C., Juan, Y.-C., Wu, Y.-C., Tsai, H.-P., … Tsai, Y.-C. (2016).  
Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve  
adult mice. Brain Research, 1631, 1–12. https://doi.org/10.1016/j.brainres.2015.11.018 
Logan, A. C., & Katzman, M. (2005). Major depressive disorder: probiotics may be an adjuvant  
therapy. Medical Hypotheses, 64(3), 533–538.  
https://doi.org/10.1016/j.mehy.2004.08.019 
Ma, D., Forsythe, P., & Bienenstock, J. (2004). Live Lactobacillus reuteri Is Essential for the  
Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression.  
Infection and Immunity, 72(9), 5308–5314.  
https://doi.org/10.1128/IAI.72.9.5308-5314.2004 
Mangiola, F., Ianiro, G., Franceschi, F., Fagiuoli, S., Gasbarrini, G., Gasbarrini, A. (2016). Gut  
microbiota in autism and mood disorders. World Journal of Gastroenterology, 22(1),  
361-368. http://dx.doi.org/10.3748/wjg.v22.i1.361 
Martínez, I., Lattimer, J. M., Hubach, K. L., Case, J. A., Yang, J., Weber, C. G., … Walter, J.  
(2013). Gut microbiome composition is linked to whole grain-induced immunological  






A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     24 
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., … Cazaubiel, J.-M.   
(2011). Assessment of psychotropic-like properties of a probiotic formulation 
Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 in rats and human 
subjects. British Journal of Nutrition, 105(5), 755–764. 
https://doi.org/10.1017/S0007114510004319 
Moncrieff, J., & Kirsch, I. (2005). Efficacy of antidepressants in adults. BMJ, 331(7509),  
155–157. https://doi.org/10.1136/bmj.331.7509.155 
National Institute of Mental Health. (2018). Depression. Retrieved from  
https://www.nimh.nih.gov/health/topics/depression/index.shtml 
Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., … Berick, P.  
(2017). Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores  
and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.  
Gastroenterology. 153(2). 448-459. https://doi.org/10.1053/j.gastro.2017.05.003 
Popa, T., & Ladea, M. (2012). Nutrition and depression at the forefront of progress. Journal of  
Medicine and Life, 5(4), 414–419. 
Psaltopoulou, T., Sergentanis, T. N., Panagiotakos, D. B., Sergentanis, I. N., Kosti, R., &  
Scarmeas, N. (2013). Mediterranean diet, stroke, cognitive impairment, and depression:  
A meta‐analysis. Annals of Neurology, 74(4), 580–591. https://doi.org/10.1002/ana.23944 
Sanchez-Villegas, A., Henríquez, P., Figueiras, A., Ortuño, F., Lahortiga, F., &  
Martínez-González, M. A. (2007). Long chain omega-3 fatty acids intake, fish  
consumption and mental disorders in the SUN cohort study. European Journal of  
Nutrition, 46(6), 337–346. https://doi.org/10.1007/s00394-007-0671-x 
 
 
A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     25 
Sandhu, K. V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017).  
Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry.  
Translational Research, 179, 223–244. https://doi.org/10.1016/j.trsl.2016.10.002 
Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids.  
Biomedicine & Pharmacotherapy, 56(8), 365–379.  
https://doi.org/10.1016/S0753-3322(02)00253-6 
Singh, R. K., Chang, H.-W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., … Liao, W. (2017).  
Influence of diet on the gut microbiome and implications for human health. Journal of  
Translational Medicine, 15. https://doi.org/10.1186/s12967-017-1175-y 
Slykerman, R. F., Hood, F., Wickens, K., Thompson, J. M. D., Barthow, C., Murphy, R., …  
Probiotic in Pregnancy Study Group. (2017). Effect of Lactobacillus rhamnosus HN001  
in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised  
Double-blind Placebo-controlled Trial. EBioMedicine, 24, 159–165.  
https://doi.org/10.1016/j.ebiom.2017.09.013 
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017). Biomarkers for depression: recent  
insights, current challenges and future prospects. Neuropsychiatric Disease and  
Treatment, 13, 1245–1262. https://doi.org/10.2147/NDT.S114542 
Steenbergen, L., Sellaro, R., Hermet, S.V., Bosch, J. A., Colzato, L.S. (2015). A randomized  
controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad  





A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS                                                     26 
Trichopoulou, A. (2004). Traditional Mediterranean diet and longevity in the elderly: a review.  
Public Health Nutrition, 7(7), 943–947. 
Wallace, C. J. K., & Milev, R. (2017). The effects of probiotics on depressive symptoms in  
humans: a systematic review. Annals of General Psychiatry, 16, 14.  
http://doi.org/10.1186/s12991-017-0138-2 
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., … Flint, H. J.  
(2011). Dominant and diet-responsive groups of bacteria within the human colonic  
microbiota. The ISME Journal, 5(2), 220–230. https://doi.org/10.1038/ismej.2010.118 
Wang, H. Lee, I., Braun, C., Enck, P. (2016). Effect of probiotics on central nervous system  
functions in animals and humans: A systematic review. Journal of 
Neurogastroenterology and Motility, 22(4), 589-605. http://ds.doi.org/10.5056/jnm16018 
World Health Organization. (2018). Depression. Retrieved from  
http://www.who.int/en/news-room/fact-sheets/detail/depression 
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., … Xie, P. (2016). Gut microbiome  
remodeling induces depressive-like behaviors through a pathway mediated by the host’s  
metabolism. Molecular Psychiatry, 21(6), 786–796. https://doi.org/10.1038/mp.2016 
